Antibacterial prescription patterns within the hospital setting are distinct from those seen within the community. Increasing age and severity of infection alongside concerns regarding pathogen resistance make the hospital segment a keen focus area for many manufacturers, but these factors also present unique and tough challenges that now threaten future investment in this field.

Detailed segmentation of the hospital antibacterial market, including annual sales by country, product and type of infection

In depth strategic analyses focusing on pricing and reimbursement, successful product characteristics and optimal positioning and promotion

Accompanying market evaluations to 2008, with sales forecasts by country, product and type of infection

Additional epidemiology database with incidence data for key infections across the seven major markets

The hospital antibacterial market is currently valued at $8 billion - around 30% of total antibacterial sales. Of these sales, $1.4 billion can be attributed to the treatment of respiratory tract infections, a figure that will rise to $2.0 billion by 2008.

While overall antibacterial sales are forecast to be relatively flat to 2008, hospital sales are expected to increase more rapidly. The majority of this growth will be driven by uptake of novel or generic products, while current leaders will face tough challenges to maintain sales.

Responsibility for the care and treatment of the patient is shared between a variety of health professionals - companies marketing antibacterials may need to re-evaluate promotional strategy to reach a selection of physicians, pharmacists and microbiologists.

Gain expert-led insight into factors that define the hospital sector, such as drug-resistance, infection control and cost-containment

Understand drivers of prescription choice, including product characteristics, treatment guidelines and information networks within a clinical setting

Support R&D prioritization decisions through clear understanding of hospital market segmentation by product and type of infection.